In this case –“Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity” (Dash et alPNAS2011, PubPeerhere) – concerns about the problematic Figure 4C were rendered moot by aCorrection, though it didn’t really explain...